PLoS ONE · 2012 · 25 citations · 42 references
PharmacyImmunologyPharmaceuticsDrug DeliveryNanoparticle Drug DeliveryTargeted Drug DeliveryNanomaterials For Drug DeliveryNanomedicineNanoparticle Delivery SystemsNanotoxicologyQuantum Dots In BiologyVaginal Drug DeliveryCellular Trafficking Of NanoparticlesIn Vivo StudiesIntracellular Nanoparticle TransportIntravaginal TherapyNanocarrier-mediated PermeationNanoparticlesQuantum Dot Drug DeliveryVaginal Nanoparticles
To test the feasibility of localized intravaginal therapy directed to neighboring lymph nodes, the transport of quantum dots across the vaginal wall was investigated. Quantum dots instilled into the mouse vagina were transported across the vaginal mucosa into draining lymph nodes, but not into distant nodes. Most of the particles were transported to the lumbar nodes; far fewer were transported to the inguinal nodes. A low level of transport was evident at 4 hr after intravaginal instillation, and transport peaked at about 36 hr after instillation. Transport was greatly enhanced by prior vaginal instillation of Nonoxynol-9. Hundreds of micrograms of nanoparticles/kg tissue (ppb) were found in the lumbar lymph nodes at 36 hr post-instillation. Our results imply that targeted transport of microbicides or immunogens from the vagina to local lymph organs is feasible. They also offer an in vivo model for assessing the toxicity of compounds intended for intravaginal use.
42
Near-infrared fluorescent type II quantum dots for sentinel lymph node mapping
Sungjee Kim, Yong Taik Lim, Edward G. Soltesz et al. · Nature Biotechnology · 2003 · 2.1K citations
Noninvasive Imaging of Quantum Dots in Mice
Byron Ballou, B. Christoffer Lagerholm, Lauren A. Ernst et al. · Bioconjugate Chemistry · 2003 · 1.1K citations
Natural Sciences, Biomedical Engineering, Materials Science +17